Pasithea Therapeutics Corp.(KTTA)

Biotechnology · Miami Beach, FL

$0.45-0.01 (-1.74%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T20:12:17.615Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:12:17.615Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -2.46
Quote price: 0.447

FMP input reference: b407bf9ab9426f7f8731c51b1e955f2cfcbe23f9f3e819a9868889fb687bb4da

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

KTTA Earnings Yield Metrics

EARNINGS YIELD

N/A

KTTA Competitors' Earnings Yield

KTTA

Pasithea Therapeutics Corp.

Current

Market Cap

$14.94M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPTI

Karyopharm Therapeutics Inc.

vs KTTA

Market Cap

$14.73M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCP

Cocrystal Pharma, Inc.

vs KTTA

Market Cap

$15.30M

Earnings Yield

N/A

TTM Avg

0.79%

3Y Avg

0.79%

5Y Avg

0.82%

HIND

Vyome Holdings, Inc.

vs KTTA

Market Cap

$14.46M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ZJYL

Jin Medical International Ltd.

vs KTTA

Market Cap

$15.58M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALLR

Allarity Therapeutics, Inc.

vs KTTA

Market Cap

$15.68M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLSM

Pulsenmore Ltd. Ordinary Shares

vs KTTA

Market Cap

$14.11M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BCDA

BioCardia, Inc.

vs KTTA

Market Cap

$15.78M

Earnings Yield

N/A

TTM Avg

4.38%

3Y Avg

3.50%

5Y Avg

25.86%

SINT

Sintx Technologies, Inc.

vs KTTA

Market Cap

$13.86M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OBX

Obsidian Therapeutics Inc.

vs KTTA

Market Cap

$13.75M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Pasithea Therapeutics Corp. (KTTA)	$14.94M	N/A	N/A	N/A	N/A
Karyopharm Therapeutics Inc. (KPTI)vs ›	$14.73M	N/A	N/A	N/A	N/A
Cocrystal Pharma, Inc. (COCP)vs ›	$15.30M	N/A	0.79%	0.79%	0.82%
Vyome Holdings, Inc. (HIND)vs ›	$14.46M	N/A	N/A	N/A	N/A
Jin Medical International Ltd. (ZJYL)vs ›	$15.58M	N/A	N/A	N/A	N/A
Allarity Therapeutics, Inc. (ALLR)vs ›	$15.68M	N/A	N/A	N/A	N/A
Pulsenmore Ltd. Ordinary Shares (PLSM)vs ›	$14.11M	N/A	N/A	N/A	N/A
BioCardia, Inc. (BCDA)vs ›	$15.78M	N/A	4.38%	3.50%	25.86%
Sintx Technologies, Inc. (SINT)vs ›	$13.86M	N/A	N/A	N/A	N/A
Obsidian Therapeutics Inc. (OBX)vs ›	$13.75M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

KTTA Earnings Yield Metrics

KTTA Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics